$AXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AOXING PHARMACEUTICAL COMPANY, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AOXING PHARMACEUTICAL COMPANY, INC.. Get notifications about new insider transactions in AOXING PHARMACEUTICAL COMPANY, INC. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2015 | AXN | AOXING PHARMACEUTI ... | Zhang Guoan | Senior Vice Preside ... | Grant | A | 1.36 | 20,000 | 27,200 | 1,370,125 | 1.4 M to 1.4 M (+1.48 %) |
| Apr 29 2015 | AXN | AOXING PHARMACEUTI ... | Chow Wilfred | Chief Financial Off ... | Grant | A | 1.36 | 100,000 | 136,000 | 1,212,500 | 1.1 M to 1.2 M (+8.99 %) |
| Feb 09 2015 | AXN | AOXING PHARMACEUTI ... | Chow Wilfred | Chief Financial Off ... | Grant | A | 0.32 | 812,500 | 260,000 | 1,112,500 | 300 K to 1.1 M (+270.83 %) |
| Feb 09 2015 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chief Executive Off ... | Grant | A | 0.39 | 7,289,199 | 2,842,788 | 12,161,375 | 4.9 M to 12.2 M (+149.61 %) |
| Feb 09 2015 | AXN | AOXING PHARMACEUTI ... | Zhang Guoan | Vice President | Grant | A | 0.26 | 356,473 | 92,683 | 1,350,125 | 993.7 K to 1.4 M (+35.88 %) |
| Feb 09 2015 | AXN | AOXING PHARMACEUTI ... | Zhang Guoan | Vice President | Grant | A | 0.39 | 831,152 | 324,149 | 993,652 | 162.5 K to 993.7 K (+511.48 %) |
| Jul 17 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.33 | 22,222 | 7,333 | 570,914 | 548.7 K to 570.9 K (+4.05 %) |
| Jul 17 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.31 | 23,656 | 7,333 | 548,692 | 525 K to 548.7 K (+4.51 %) |
| Jul 17 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.38 | 19,298 | 7,333 | 525,036 | 505.7 K to 525 K (+3.82 %) |
| Jun 19 2012 | AXN | AOXING PHARMACEUTI ... | Ai Bob Yunjun | Chief Financial Off ... | Grant | A | 0.23 | 20,000 | 4,600 | 20,000 | 0 to 20 K |
| Jun 13 2012 | AXN | AOXING PHARMACEUTI ... | Xu Guozhu | Director | Grant | A | 0.26 | 20,000 | 5,200 | 80,000 | 60 K to 80 K (+33.33 %) |
| Jun 13 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.26 | 20,000 | 5,200 | 505,738 | 485.7 K to 505.7 K (+4.12 %) |
| May 09 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.39 | 18,804 | 7,334 | 485,738 | 466.9 K to 485.7 K (+4.03 %) |
| May 09 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.44 | 16,667 | 7,333 | 466,934 | 450.3 K to 466.9 K (+3.70 %) |
| May 09 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.39 | 18,804 | 7,334 | 450,267 | 431.5 K to 450.3 K (+4.36 %) |
| Jun 13 2012 | AXN | AOXING PHARMACEUTI ... | Ai Bob Yunjun | CFO | Option Exercise | A | 0.41 | 50,000 | 20,500 | 100,000 | |
| Jan 24 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.34 | 21,569 | 7,333 | 431,463 | 409.9 K to 431.5 K (+5.26 %) |
| Jan 24 2012 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.41 | 18,887 | 7,744 | 409,894 | 391 K to 409.9 K (+4.83 %) |
| Nov 23 2011 | AXN | AOXING PHARMACEUTI ... | Xu Guozhu | Director | Grant | A | 0.40 | 20,000 | 8,000 | 60,000 | 40 K to 60 K (+50.00 %) |
| Nov 23 2011 | AXN | AOXING PHARMACEUTI ... | Sterling Howard David | Director | Grant | A | 0.40 | 20,000 | 8,000 | 60,000 | 40 K to 60 K (+50.00 %) |
| Nov 23 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.40 | 20,000 | 8,000 | 391,007 | 371 K to 391 K (+5.39 %) |
| Nov 23 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 0.59 | 59,783 | 35,272 | 371,007 | 311.2 K to 371 K (+19.21 %) |
| Jul 11 2011 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman & CEO | Buy | J | 2.70 | 802,176 | 2,165,875 | 4,872,176 | 4.1 M to 4.9 M (+19.71 %) |
| Jun 27 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 1.44 | 5,093 | 7,334 | 311,224 | 306.1 K to 311.2 K (+1.66 %) |
| Jun 20 2011 | AXN | AOXING PHARMACEUTI ... | Zhang Guoan | Senior VP of Financ ... | Buy | P | 1.07 | 4,300 | 4,618 | 73,800 | 69.5 K to 73.8 K (+6.19 %) |
| Jun 17 2011 | AXN | AOXING PHARMACEUTI ... | Zhang Guoan | Senior VP of Financ ... | Buy | P | 0.95 | 47,000 | 44,641 | 69,500 | 22.5 K to 69.5 K (+208.89 %) |
| Jun 01 2011 | AXN | AOXING PHARMACEUTI ... | Sterling Howard David | Director | Grant | A | 1.84 | 20,000 | 36,800 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 31 2011 | AXN | AOXING PHARMACEUTI ... | Xu Guozhu | Director | Grant | A | 1.84 | 20,000 | 36,800 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 31 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 1.84 | 20,000 | 36,800 | 306,131 | 286.1 K to 306.1 K (+6.99 %) |
| May 23 2011 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman, C.E.O. | Grant | A | 2.04 | 40,000 | 81,600 | 4,070,000 | 4 M to 4.1 M (+0.99 %) |
| May 23 2011 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman, C.E.O. | Grant | A | 1.94 | 50,000 | 97,000 | 4,050,000 | 4 M to 4.1 M (+1.25 %) |
| May 09 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 1.95 | 3,761 | 7,334 | 286,131 | 282.4 K to 286.1 K (+1.33 %) |
| Apr 12 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 2.16 | 3,395 | 7,333 | 282,370 | 279 K to 282.4 K (+1.22 %) |
| Mar 04 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 2.05 | 3,577 | 7,333 | 278,975 | 275.4 K to 279 K (+1.30 %) |
| Feb 11 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Grant | A | 2.15 | 3,411 | 7,334 | 275,398 | 272 K to 275.4 K (+1.25 %) |
| Jan 20 2011 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Buy | P | 2.59 | 7,205 | 18,661 | 271,987 | 264.8 K to 272 K (+2.72 %) |
| Jan 20 2010 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Buy | P | 0.97 | 40,000 | 38,800 | 481,076 | 441.1 K to 481.1 K (+9.07 %) |
| Jan 20 2010 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Buy | P | 0.85 | 4,706 | 4,000 | 441,076 | 436.4 K to 441.1 K (+1.08 %) |
| Jan 20 2010 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Buy | P | 1.07 | 3,738 | 4,000 | 436,370 | 432.6 K to 436.4 K (+0.86 %) |
| Aug 07 2009 | AXN | AOXING PHARMACEUTI ... | OSHEA JOHN P | Director | Buy | P | 0.95 | 432,632 | 411,000 | 432,632 | 0 to 432.6 K |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Leo John | Secretary | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Leo John | Secretary | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Leo John | Secretary | Buy | C | 0.00 | 750,000 | 0 | 1,000,000 | 250 K to 1000 K (+300.00 %) |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Leo John | Secretary | Buy | C | 0.00 | 150,000 | 0 | 200,000 | 50 K to 200 K (+300.00 %) |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman | Option Exercise | C | 0.00 | 9,000,000 | 0 | 0 | |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman | Buy | C | 0.00 | 2,250,000 | 0 | 3,000,000 | 750 K to 3 M (+300.00 %) |
| Nov 03 2006 | AXN | AOXING PHARMACEUTI ... | Yue Zhenjiang | Chairman | Buy | C | 0.00 | 3,750,000 | 0 | 5,000,000 | 1.3 M to 5 M (+300.00 %) |
| Sep 22 2005 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Buy | P | 0.11 | 6,500 | 715 | 212,120 | 205.6 K to 212.1 K (+3.16 %) |
| May 09 2005 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Option Exercise | P | 0.04 | 500,000 | 20,000 | 300,000 | |
| May 09 2005 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Option Exercise | A | 0.04 | 500,000 | 20,000 | 800,000 | |
| May 09 2005 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Buy | P | 0.04 | 500,000 | 20,000 | 2,056,202 | 1.6 M to 2.1 M (+32.13 %) |
| Apr 08 2005 | AXN | AOXING PHARMACEUTI ... | TALLEY RICHARD WM | Director | Grant | A | 40,000.00 | 1,000,000 | 40,000,000,000 | 1,742,431 | 742.4 K to 1.7 M (+134.69 %) |
| Mar 01 2005 | AXN | AOXING PHARMACEUTI ... | Voloshin Peter James | Secretary | Grant | A | 0.00 | 25,000 | 0 | 1,647,015 | 1.6 M to 1.6 M (+1.54 %) |
| Dec 21 2004 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 1,556,202 | 1.5 M to 1.6 M (+1.63 %) |
| Jan 14 2004 | AXN | AOXING PHARMACEUTI ... | CAGGIANO MICHAEL N | President and CEO | Grant | A | 0.00 | 700,000 | 0 | 1,531,202 | 831.2 K to 1.5 M (+84.22 %) |
Page: 1